For investors in gene therapy biotech bluebird bio, a wait-and-see approach toward a proposed acquisition has paid off. | For ...

Kyndryl ( Nasdaq:KD) and Microsoft ( Nasdaq:MSFT) broadened their existing partnership to bring together Microsoft’s adaptive ...

The Toronto Maple Leafs face an intriguing contract dilemma with rising star Matthew Knies — one that could be influenced by ...